EPIRUS Biopharma (EPRS) Misses Q3 EPS by 8c; Updates on BOW015 as RA Treatment

Go back to EPIRUS Biopharma (EPRS) Misses Q3 EPS by 8c; Updates on BOW015 as RA Treatment

Form 8-K EPIRUS Biopharmaceutical For: Nov 16

November 16, 2015 6:12 AM EST

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

... More